IgG subclass responses to Pseudomonas aeruginosa a- and b-type flagellins in patients with cystic fibrosis: A prospective study
Department of Microbiology and Immunology, UniversitÉ de MontrÉal, CP 6128, Succursale Centre-ville, Montreal, Quebec H3C 3J7, Canada * Department of Microbiology, University of Tennessee, Knoxville, Tennessee 37996, USA Received November 15, 1994 Accepted February 14, 1995 Sera from 20 cystic fibro...
Saved in:
Published in | Journal of medical microbiology Vol. 43; no. 4; pp. 270 - 276 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Reading
Soc General Microbiol
01.10.1995
Society for General Microbiology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Department of Microbiology and Immunology, UniversitÉ de MontrÉal, CP 6128, Succursale Centre-ville, Montreal, Quebec H3C 3J7, Canada
* Department of Microbiology, University of Tennessee, Knoxville, Tennessee 37996, USA
Received November 15, 1994
Accepted February 14, 1995
Sera from 20 cystic fibrosis patients, whose lungs were colonised by Pseudomonas aeruginosa , were examined in a 3-5-year prospective study for any relationship between IgG subclass antibody levels to P. aeruginosa a- and b-type flagellins and pulmonary function (FEV 1 and radiological score). Patients were divided into two groups according to their pulmonary status: Group 1 comprised 11 patients with poor pulmonary status; group 2 comprised nine patients with relatively good pulmonary status. High concentrations of IgG1, IgG2 and IgG3 antibodies to flagellins, particularly to the b-type, were found in most patients. IgG4 reactivity was observed in only a few patients. Comparison of the two groups of patients showed that those with poor pulmonary status (group 1) had a significantly higher concentration (p << 0·05) of IgG3 for two of the three periods studied and of IgG2 for the last period studied. Moreover, IgG3 and IgG1 reactivities to b-type flagellin and IgG3 to a-type flagellin were also increased significantly (p << 0·05) in group 1 patients between the first and the last period studied. These patients also showed a significant (p << 0·05) time-dependent increase in IgG3 and IgG1 antibody concentrations. These data demonstrate that cystic fibrosis patients with poorer pulmonary status have higher IgG3 levels to flagellin than other cystic fibrosis patients. High concentrations of strong opsonic IgG3 and, to a lesser degree, of IgG1 antibodies may increase pulmonary inflammation and induce heightened pulmonary deterioration. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0022-2615 1473-5644 |
DOI: | 10.1099/00222615-43-4-270 |